1-150960754-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001366418.1(SETDB1):​c.2695C>G​(p.Pro899Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

SETDB1
NM_001366418.1 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.79

Publications

0 publications found
Variant links:
Genes affected
SETDB1 (HGNC:10761): (SET domain bifurcated histone lysine methyltransferase 1) This gene encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. This gene has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. Alternatively spliced transcript variants of this gene have been described.[provided by RefSeq, Jun 2011]
CERS2 (HGNC:14076): (ceramide synthase 2) This gene encodes a protein that has sequence similarity to yeast longevity assurance gene 1. Mutation or overexpression of the related gene in yeast has been shown to alter yeast lifespan. The human protein may play a role in the regulation of cell growth. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.059517384).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SETDB1NM_001366418.1 linkc.2695C>G p.Pro899Ala missense_variant Exon 16 of 22 ENST00000692827.1 NP_001353347.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SETDB1ENST00000692827.1 linkc.2695C>G p.Pro899Ala missense_variant Exon 16 of 22 NM_001366418.1 ENSP00000509425.1 A0A8I5KT93

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.86e-7
AC:
1
AN:
1458772
Hom.:
0
Cov.:
35
AF XY:
0.00000138
AC XY:
1
AN XY:
725654
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33410
American (AMR)
AF:
0.00
AC:
0
AN:
44436
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25806
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53270
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1110402
Other (OTH)
AF:
0.00
AC:
0
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 09, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2692C>G (p.P898A) alteration is located in exon 16 (coding exon 15) of the SETDB1 gene. This alteration results from a C to G substitution at nucleotide position 2692, causing the proline (P) at amino acid position 898 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.052
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Benign
0.10
T;.;T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.74
T;T;T
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.060
T;T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
-0.20
N;N;.
PhyloP100
1.8
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.55
N;N;N
REVEL
Benign
0.085
Sift
Benign
0.24
T;T;T
Sift4G
Benign
0.46
T;T;T
Polyphen
0.39
B;B;B
Vest4
0.13
MutPred
0.29
Loss of glycosylation at T895 (P = 0.1228);Loss of glycosylation at T895 (P = 0.1228);Loss of glycosylation at T895 (P = 0.1228);
MVP
0.54
MPC
0.70
ClinPred
0.16
T
GERP RS
3.6
Varity_R
0.073
gMVP
0.20
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr1-150933230; API